BMS Buys MyoKardia, Plans To Use Eliquis Experience To Grow Mavacamten

Company Sees Opportunity For A Similar Ramp-Up For The Cardiovascular Drug

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.